Lixte Biotechnology Holdings Inc. (NASDAQ: LIXT) Featured in Coverage of Sidoti’s Virtual Microcap Conference
Lixte Biotechnology Holdings Inc. (NASDAQ: LIXT) is a clinical-stage pharmaceutical company dedicated to discovering drugs for more effective treatments for many forms of cancer and other serious common diseases. A major driver of cancer is defects in the switches that turn the biochemical pathways in cells on and off. The company's innovative approach encourages cancer cells, damaged by chemo or other cancer therapies, to continue…